Modelling the costs and effects of leflunomide in rheumatoid arthritis
Year of publication: |
2002
|
---|---|
Authors: | Kobelt, G. ; Lindgren, P. ; Young, A. |
Published in: |
The European Journal of Health Economics. - Springer. - Vol. 3.2002, 3, p. 180-187
|
Publisher: |
Springer |
Subject: | Keywords Leflunomide | Rheumatoid arthritis | Cost-effectiveness | Utility | Quality-adjusted life-year | Cost |
-
Health technology assessment with risk aversion in health
Lakdawalla, Darius, (2020)
-
An exponential representation of health state utility
Happich, Michael, (2003)
-
Hernández-Alava, Mónica, (2017)
- More ...
-
Areas of biofilters for the biological waste air purification in food production industry
Kobelt, G., (1998)
-
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
Jönsson, B., (2008)
-
The burden of rheumatoid arthritis and access to treatment: health burden and costs
Lundkvist, J., (2008)
- More ...